{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:25:30Z","timestamp":1761895530046,"version":"3.44.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,10]],"date-time":"2013-11-10T00:00:00Z","timestamp":1384041600000},"content-version":"vor","delay-in-days":374,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.virol.2012.07.014","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T21:30:48Z","timestamp":1345757448000},"page":"192-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins"],"prefix":"10.1016","volume":"433","author":[{"given":"Ghada","family":"Khawaja","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Buronfosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Jamard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Abdul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylviane","family":"Guerret","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabien","family":"Zoulim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Luxembourg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew","family":"Hannaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire F.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucyna","family":"Cova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.virol.2012.07.014_bib1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bioelechem.2006.10.003","article-title":"A single HBsAg DNA vaccination in combination with electroporation elicits long-term antibody responses in sheep","volume":"70","author":"Babiuk","year":"2007","journal-title":"Bioelectrochemistry"},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/jhep.2003.50310","article-title":"Kinetics of the immune response during HBV and HCV infection","volume":"38","author":"Bertoletti","year":"2003","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/mt.2009.5","article-title":"Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments","volume":"17","author":"Bodles-Brakhop","year":"2009","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.virol.2012.07.014_bib4","doi-asserted-by":"crossref","first-page":"e14626","DOI":"10.1371\/journal.pone.0014626","article-title":"Partially randomized, non-blinded trial of DNA and MVA therapeutic vaccines based on hepatitis B virus surface protein for chronic HBV infection","volume":"6","author":"Cavenaugh","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib5","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/viro.1993.1024","article-title":"Fine mapping of neutralization epitopes on duck hepatitis B virus (DHBV) pre-S protein using monoclonal antibodies and overlapping peptides","volume":"192","author":"Chassot","year":"1993","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib6","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1006\/viro.1994.1164","article-title":"Identification of major antigenic domains of duck hepatitis B virus pre-S protein by peptide scanning","volume":"200","author":"Chassot","year":"1994","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.virol.2012.07.014_bib7","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1128\/CVI.05113-11","article-title":"Enhanced effect of DNA immunization plus in vivo electroporation with a combination of hepatitis B virus core-PreS1 and S-PreS1 plasmids","volume":"18","author":"Chen","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"2\u20133","key":"10.1016\/j.virol.2012.07.014_bib8","first-page":"261","article-title":"Hepatitis B virus immunopathology","volume":"17","author":"Chisari","year":"1995","journal-title":"Springer Semin. Immunopathol."},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib9","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.patbio.2009.11.001","article-title":"Pathogenesis of hepatitis B virus infection","volume":"58","author":"Chisari","year":"2010","journal-title":"Pathol. Biol."},{"issue":"2","key":"10.1016\/j.virol.2012.07.014_bib10","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2217\/fvl.11.145","article-title":"Progress in DNA vaccination against HBV infection","volume":"7","author":"Cova","year":"2012","journal-title":"Future Virol."},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib11","first-page":"2156","article-title":"Contribution of aflatoxin B1 and hepatitis B virus infection in the induction of liver tumors in ducks","volume":"50","author":"Cova","year":"1990","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2012.07.014_bib12","first-page":"261","article-title":"Duck hepatitis B virus model in the study of hepatitis B virus","volume":"96","author":"Cova","year":"2004","journal-title":"Methods Mol. Med."},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib13","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.vaccine.2010.11.011","article-title":"Immunogenicity, safety, biodistribution and persistence of ADVAX, a prophylactic DNA vaccine for HIV-1, delivered by in vivo electroporation","volume":"29","author":"Dolter","year":"2011","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib14","doi-asserted-by":"crossref","first-page":"e19181","DOI":"10.1371\/journal.pone.0019181","article-title":"Evaluation of a novel non-penetrating electrode for use in DNA vaccination","volume":"6","author":"Donate","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.virol.2012.07.014_bib15","doi-asserted-by":"crossref","first-page":"3442","DOI":"10.4049\/jimmunol.145.10.3442","article-title":"Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection","volume":"145","author":"Ferrari","year":"1990","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2012.07.014_bib16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1146\/annurev.immunol.19.1.65","article-title":"Noncytolytic control of viral infections by the innate and adaptive immune response","volume":"19","author":"Guidotti","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"5415","key":"10.1016\/j.virol.2012.07.014_bib17","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1126\/science.284.5415.825","article-title":"Viral clearance without destruction of infected cells during acute HBV infection","volume":"284","author":"Guidotti","year":"1999","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.virol.2012.07.014_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1053\/jhep.2001.29004","article-title":"Augmented hepatic interferon gamma expression and T-cell influx characterize acute hepatitis progressing to recovery and residual lifelong virus persistence in experimental adult woodchuck hepatitis virus infection","volume":"34","author":"Hodgson","year":"2001","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.virol.2012.07.014_bib19","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1128\/jvi.66.3.1377-1388.1992","article-title":"Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement","volume":"66","author":"Jilbert","year":"1992","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2012.07.014_bib20","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1128\/jvi.69.6.3358-3368.1995","article-title":"Activation of a heterogeneous hepatitis B (HB) core and e antigen-specific CD4+ T-cell population during seroconversion to anti-HBe and anti-HBs in hepatitis B virus infection","volume":"69","author":"Jung","year":"1995","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.virol.2012.01.001","article-title":"Enhanced magnitude and breadth of neutralizing humoral response to a DNA vaccine targeting the DHBV envelope protein delivered by in vivo electroporation.","volume":"425","author":"Khawaja","year":"2012","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.virol.2012.07.014_bib22","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3858\/emm.2008.40.6.669","article-title":"Increased in vivo immunological potency of HB-110, a novel therapeutic HBV DNA vaccine, by electroporation","volume":"40","author":"Kim","year":"2008","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib23","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0042-6822(91)90796-E","article-title":"In vivo neutralization of duck hepatitis B virus by antibodies specific to the N-terminal portion of pre-S protein","volume":"185","author":"Lambert","year":"1991","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1128\/AAC.44.1.111-122.2000","article-title":"Characterization of the antiviral effect of 2\u2032,3\u2032-dideoxy-2\u2032,3\u2032-didehydro-beta-L-5-fluorocytidine in the duck hepatitis B virus infection model","volume":"44","author":"Le Guerhier","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"issue":"3","key":"10.1016\/j.virol.2012.07.014_bib25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0168-8278(02)00425-7","article-title":"Antiviral effect of adefovir in combination with a DNA vaccine in the duck hepatitis B virus infection model","volume":"38","author":"Le Guerhier","year":"2003","journal-title":"J. Hepatol."},{"issue":"19","key":"10.1016\/j.virol.2012.07.014_bib26","doi-asserted-by":"crossref","first-page":"12242","DOI":"10.1128\/JVI.79.19.12242-12252.2005","article-title":"Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection","volume":"79","author":"Le Mire","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.virol.2012.07.014_bib27","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1128\/JVI.02437-10","article-title":"Electroporation enhances immunogenicity of a DNA vaccine expressing woodchuck hepatitis virus surface antigen in woodchucks","volume":"85","author":"Liu","year":"2011","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib28","first-page":"61","article-title":"Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants","volume":"22","author":"Lohr","year":"1995","journal-title":"Hepatology"},{"issue":"11","key":"10.1016\/j.virol.2012.07.014_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1089\/hum.2009.067","article-title":"DNA vaccination with electroporation induces increased antibody responses in patients with prostate cancer","volume":"20","author":"Low","year":"2009","journal-title":"Hum. Gene Ther."},{"issue":"10","key":"10.1016\/j.virol.2012.07.014_bib30","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1128\/JVI.00055-07","article-title":"Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques","volume":"81","author":"Luckay","year":"2007","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.virol.2012.07.014_bib31","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1016\/j.vaccine.2005.08.014","article-title":"Enhancement of immune responses to an HBV DNA vaccine by electroporation","volume":"24","author":"Luxembourg","year":"2006","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.virol.2012.07.014_bib32","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2008.05.021","article-title":"Immunogenicity in mice and rabbits of DNA vaccines expressing woodchuck hepatitis virus antigens","volume":"26","author":"Luxembourg","year":"2008","journal-title":"Vaccine"},{"issue":"4 Pt 1","key":"10.1016\/j.virol.2012.07.014_bib33","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/hep.1840220405","article-title":"Induction of T-helper cell response to hepatitis B core antigen in chronic hepatitis B: a major factor in activation of the host immune response to the hepatitis B virus","volume":"22","author":"Marinos","year":"1995","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.virol.2012.07.014_bib34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/hep.1840190219","article-title":"Characterization of the antiviral effects of 2\u2032 carbodeoxyguanosine in ducks chronically infected with duck hepatitis B virus","volume":"19","author":"Mason","year":"1994","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.virol.2012.07.014_bib35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jhep.2010.12.031","article-title":"Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: perspectives and challenges","volume":"54","author":"Michel","year":"2011","journal-title":"J. Hepatol."},{"issue":"2\u20133","key":"10.1016\/j.virol.2012.07.014_bib36","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000050035","article-title":"DNA vaccines for prophylactic or therapeutic immunization against hepatitis B","volume":"44","author":"Michel","year":"2001","journal-title":"Intervirology"},{"issue":"Pt 11","key":"10.1016\/j.virol.2012.07.014_bib37","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1099\/vir.0.82170-0","article-title":"Rise in gamma interferon expression during resolution of duck hepatitis B virus infection","volume":"87","author":"Narayan","year":"2006","journal-title":"J. Gen. Virol."},{"issue":"12","key":"10.1016\/j.virol.2012.07.014_bib38","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1086\/652808","article-title":"Improving on the ability of endogenous hepatitis B core antigen to prime cytotoxic T lymphocytes","volume":"201","author":"Nystrom","year":"2010","journal-title":"J. Infect. Dis."},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib39","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1111\/j.1745-7254.2007.00591.x","article-title":"Non-cytolytic antigen clearance in DNA-vaccinated mice with electroporation","volume":"28","author":"Peng","year":"2007","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.virol.2012.07.014_bib40","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.191.8.1263","article-title":"Intrahepatic T cells in hepatitis B: viral control versus liver cell injury","volume":"191","author":"Rehermann","year":"2000","journal-title":"J. Exp. Med."},{"issue":"27","key":"10.1016\/j.virol.2012.07.014_bib41","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1016\/S0264-410X(00)00130-4","article-title":"Early life humoral response of ducks to DNA immunization against hepadnavirus large envelope protein","volume":"18","author":"Rollier","year":"2000","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.virol.2012.07.014_bib42","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0016-5085(99)70188-5","article-title":"Protective and therapeutic effect of DNA-based immunization against hepadnavirus large envelope protein","volume":"116","author":"Rollier","year":"1999","journal-title":"Gastroenterology"},{"issue":"9","key":"10.1016\/j.virol.2012.07.014_bib43","doi-asserted-by":"crossref","first-page":"e7226","DOI":"10.1371\/journal.pone.0007226","article-title":"Skin electroporation: effects on transgene expression, DNA persistence and local tissue environment","volume":"4","author":"Roos","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2012.07.014_bib44","series-title":"DNA Vaccines: Types, Advantages and Limitations","first-page":"119","article-title":"Co-administration of gamma interferon gene with DNA vaccine expressing Duck Hepatitis B Virus (DHBV) proteins enhances therapeutic efficacy of DNA-based immunization in chronic virus carriers","author":"Saade","year":"2011"},{"issue":"40","key":"10.1016\/j.virol.2012.07.014_bib45","doi-asserted-by":"crossref","first-page":"5159","DOI":"10.1016\/j.vaccine.2008.03.086","article-title":"Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes","volume":"26","author":"Saade","year":"2008","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1517\/14712590902988444","article-title":"DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target","volume":"9","author":"Sallberg","year":"2009","journal-title":"Expert Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.virol.2012.07.014_bib47","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.coi.2011.03.008","article-title":"Electroporation delivery of DNA vaccines: prospects for success","volume":"23","author":"Sardesai","year":"2011","journal-title":"Curr. Opin. Immunol."},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib48","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1128\/JVI.73.4.2569-2575.1999","article-title":"Residues critical for duck hepatitis B virus neutralization are involved in host cell interaction","volume":"73","author":"Sunyach","year":"1999","journal-title":"J. Virol."},{"issue":"Pt 5","key":"10.1016\/j.virol.2012.07.014_bib49","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1099\/vir.0.83583-0","article-title":"DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection","volume":"89","author":"Thermet","year":"2008","journal-title":"J. Gen. Virol."},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib50","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1128\/JVI.78.4.1945-1953.2004","article-title":"Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection","volume":"78","author":"Thermet","year":"2004","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.virol.2012.07.014_bib51","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/emboj\/19.6.1217","article-title":"Receptor recognition by a hepatitis B virus reveals a novel mode of high affinity virus-receptor interaction","volume":"19","author":"Urban","year":"2000","journal-title":"EMBO J."},{"issue":"5","key":"10.1016\/j.virol.2012.07.014_bib52","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1586\/erv.10.42","article-title":"Electroporation for DNA immunization: clinical application","volume":"9","author":"van Drunen Littel-van den Hurk","year":"2010","journal-title":"Expert Rev. Vaccines"},{"issue":"43","key":"10.1016\/j.virol.2012.07.014_bib53","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1016\/j.vaccine.2008.07.093","article-title":"Electroporation-based DNA transfer enhances gene expression and immune responses to DNA vaccines in cattle","volume":"26","author":"van Drunen Littel-van den Hurk","year":"2008","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.virol.2012.07.014_bib54","doi-asserted-by":"crossref","first-page":"e19252","DOI":"10.1371\/journal.pone.0019252","article-title":"In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers","volume":"6","author":"Vasan","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.virol.2012.07.014_bib55","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1053\/jhep.2003.50154","article-title":"Role of type 1 versus type 2 immune responses in liver during the onset of chronic woodchuck hepatitis virus infection","volume":"37","author":"Wang","year":"2003","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib56","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1053\/j.gastro.2004.03.018","article-title":"Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy","volume":"126","author":"Werle-Lapostolle","year":"2004","journal-title":"Gastroenterology"},{"issue":"15","key":"10.1016\/j.virol.2012.07.014_bib57","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1128\/JVI.79.15.9369-9380.2005","article-title":"Stealth and cunning: hepatitis B and hepatitis C viruses","volume":"79","author":"Wieland","year":"2005","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib58","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1073\/pnas.0308478100","article-title":"Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees","volume":"101","author":"Wieland","year":"2004","journal-title":"PNAS"},{"issue":"14","key":"10.1016\/j.virol.2012.07.014_bib59","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/sj.gt.3302751","article-title":"Correlation of antiviral T-cell responses with suppression of viral rebound in chronic hepatitis B carriers: a proof-of-concept study","volume":"13","author":"Yang","year":"2006","journal-title":"Gene Ther."},{"key":"10.1016\/j.virol.2012.07.014_bib65","doi-asserted-by":"crossref","unstructured":"Yang, F.-Q., Yu, Y.-Y., Wang, G.-Q., Chen, J., Li, J.-H., Li, Y.-Q., Rao, G.-R., Mo, G.-Y., Luo, X.-R., Chen, G.-M., 2012. A pilot randomized controlled trial of dual-plasmid HBV DNA vaccine mediated by in vivo electroporation in chronic hepatitis B patients under lamivudine chemotherapy. J. Viral Hepat. 10.1111\/j.1365-2893.2012.01589.x.","DOI":"10.1111\/j.1365-2893.2012.01589.x"},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib60","doi-asserted-by":"crossref","first-page":"e22524","DOI":"10.1371\/journal.pone.0022524","article-title":"DNA immunization with fusion of CTLA-4 to hepatitis B virus (HBV) core protein enhanced Th2 type responses and cleared HBV with an accelerated kinetic","volume":"6","author":"Yin","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.virol.2012.07.014_bib61","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0042-6822(91)90465-N","article-title":"Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide","volume":"181","author":"Yuasa","year":"1991","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.virol.2012.07.014_bib62","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1128\/JVI.78.3.1195-1201.2004","article-title":"Rapid production of neutralizing antibody leads to transient hepadnavirus infection","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.virol.2012.07.014_bib63","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.vaccine.2005.08.093","article-title":"Anti-HBV immune responses in rhesus macaques elicited by electroporation mediated DNA vaccination","volume":"24","author":"Zhao","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.virol.2012.07.014_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1478-3231.2010.02399.x","article-title":"Hepatitis B virus resistance to antiviral drugs: where are we going?","volume":"31","author":"Zoulim","year":"2011","journal-title":"Liver Int."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212003637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212003637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:17:03Z","timestamp":1758586623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212003637"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0042682212003637"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.07.014","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vivo electroporation improves therapeutic potency of a DNA vaccine targeting hepadnaviral proteins","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}